Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
64,379,566
-
Share change
-
-1,365,651
-
Total reported value
-
$3,473,619,148
-
Put/Call ratio
-
93%
-
Price per share
-
$53.95
-
Number of holders
-
269
-
Value change
-
-$84,334,840
-
Number of buys
-
134
-
Number of sells
-
124
Institutional Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q3 2020
As of 30 Sep 2020,
BLUEBIRD BIO INC - COM (BLUE) was held by
269 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,379,566 shares.
The largest 10 holders included
Capital Research Global Investors, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., Capital World Investors, SANDS CAPITAL MANAGEMENT, LLC, ROYAL BANK OF CANADA, STATE STREET CORP, VICTORY CAPITAL MANAGEMENT INC, and FIRST TRUST ADVISORS LP.
This page lists
269
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.